HS
Hariharan Sivaramakrishnan
About Hariharan Sivaramakrishnan
Data last updated:
Hariharan Sivaramakrishnan has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Malladi Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Malladi Drugs And Pharmaceuticals Limited at ₹627 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Malladi Drugs And Pharmaceuticals Limited U24230TN1980PLC008382 | Director | 29 Aug 2023 | 1980 | ₹627 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hariharan Sivaramakrishnan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hariharan Sivaramakrishnan
Hariharan Sivaramakrishnan has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Malladi Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Malladi Drugs And Pharmaceuticals Limited at ₹627 Cr (FY 2025).
Hariharan Sivaramakrishnan is associated with 1 company as Director, including Malladi Drugs And Pharmaceuticals Limited (₹627 Cr).
Hariharan Sivaramakrishnan has expertise in General Business.
Hariharan Sivaramakrishnan has 3 years in corporate governance.
By reported revenue, the largest current company of Hariharan Sivaramakrishnan is Malladi Drugs And Pharmaceuticals Limited, with revenue of ₹627 Cr (FY 2025).
Hariharan Sivaramakrishnan currently holds positions at 1 company: Malladi Drugs And Pharmaceuticals Limited (₹627 Cr).